发明名称 N-sugar derivs. of ortho- and meta-amino-benzoic acid - have hypoglycaemic, hypotensive, hypolipaemic, antiinflammatory, analgesic, antipyretic, and antitumour activity
摘要 <p>Aminobenzoic acid derivs. of formula R1-NH-Ph-COOR2 are new. R1 is a gp. formed by removal of the 1-alpha or 1-beta hydroxy gp. from ribose, 2-desoxyribose- fructose, sorbase, fucose, maltose, saccharose, lactose, cellobiose, malto- triose, gluconolactone, N-methyl-glucuronic acid or acetylglucosamine; R1-NH to joined in the ortho or meta position w.r.t. -COOR2; R2 is H, Na, K, 1/2Mg, 1/2Ca, 1/3Al or 1-4C alkyl. Hypoglycemic, hypotensive, hypolipaemic, antiinflammatory, anagesic, antipyretic and antitumour cpds. which may be administered orally (0.1-500, pref. 1-250, mg/kg/day) or parenterally (0.01-200, pref. 0.1-100, mg/kg/day). Extensive pharmacological tests are described e.g. antitumour activity is demonstrated against sarcoma 180 tumour transplanted in mice. The cpds. have low toxicity (LD50 in mice of tested cpds. 4.1- 11.6 g/kg) and no antibacterial activity (do not disturb intestinal bacteria) and do not effect immunity.</p>
申请公布号 FR2471984(A1) 申请公布日期 1981.06.26
申请号 FR19800026285 申请日期 1980.12.11
申请人 KUREHA KAGAKU KOGYO KK 发明人 CHIKAO YOSHIKUMI, FUMIO HIROSE, YOSHIO OHMURA, TAKAYOSHI FUJII, MASANORI IKUZAWA, MINORU OHHARA, KENICHI MATSUNAGA ET TAKAO ANDO
分类号 A61K31/70;A61K31/7028;A61K31/7034;A61P3/06;A61P3/08;A61P9/10;A61P9/12;A61P25/00;A61P25/04;A61P29/00;A61P35/00;C07H15/203;(IPC1-7):07H5/06;61K31/70 主分类号 A61K31/70
代理机构 代理人
主权项
地址